Full text
3/2026
vol. 113
Original article
Dermatoscopy and treatment of Pustular Psoriatic Balanoposthitis: a Preliminary report
Department of Dermatology and Venereology, Riga Stradin¸š University, Riga, Latvia
Academic Histology Laboratory, Riga, Latvia
Department of Internal Diseases, Riga Stradin¸š University, Riga, Latvia
Dermatol Rev/Przegl Dermatol 2026, 113, 131–134
Data publikacji online: 2026/09/09
Article file
- Kelly A., Ryan C.: Genital psoriasis: impact on quality of life and treatment options. Am J Clin Dermatol 2019, 20, 639-646.
- Edwards S.K., Bunker C.B., van der Snoek E.M., van der Meijden W.I.: 2022 European guideline for the management of balanoposthitis. J Eur Acad Dermatol Venereol 2023, 37, 1104-1117.
- Borghi A., Virgili A., Corazza M.: Dermoscopy of inflammatory genital diseases: practical insights. Dermatol Clin 2018, 36, 451-461.
- Errichetti E.: Dermoscopy in monitoring and predicting therapeutic response in general dermatology (non-tumoral dermatoses): an up-to-date overview. Dermatol Ther 2020, 10, 1199-1214.
- Singh N., Thappa D.M. : Circinate pustular psoriasis localized to glans penis mimicking ‘circinate balanitis’ and responsive to dapsone. Indian J Dermatol Venereol Leprol 2008, 74, 388-389.
- Navarini A.A., Burden A.D., Capon F., Mrowietz U., Puig L., Köks S., et al.: European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol 2017, 31, 1792-1799.
- Daroach M., Vinay K., Kumaran M.S.: Pseudo circinate balanitis: great masquerader lives. Postgrad Med J 2019, 95, 283.
- Benjegerdes K.E., Hyde K., Kivelevitch D., Mansouri B.: Pustular psoriasis: pathophysiology and current treatment perspectives. Psoriasis 2016, 6, 131-144.
- Amiri D., Schwarz C.W., Gether L., Skov L.: Safety and efficacy of topical calcineurin inhibitors in the treatment of facial and genital psoriasis: a systematic review. Acta Derm Venereol 2023, 103, adv00890.
- Ortiz-Alvarez J., Hernandez-Rodriguez J.C., Sanchez J.C., Barabash-Neila R.: Postcircumcision psoriatic balanoposthitis: an undescribed expression of Koebner’s phenomenon. Asian J Androl 2022, 24, 219-220.
- Guenther L., Potts Bleakman A., Weisman J., Poulin Y., Spelman L., Burge R., et al.: Ixekizumab results in persistent clinical improvement in moderate-to-severe genital psoriasis during a 52 week, randomized, <i>placebo</i>-controlled, phase 3 clinical trial. Acta Derm Venereol 2020, 100, adv00006.
- Orsini D., Frascione P., Assorgi C., Pacifico A., Sperduti I., Gargiulo L., et al.: Risankizumab for the treatment of genital psoriasis: a 1-year, real-world experience. J Eur Acad Dermatol Venereol 2024, 38, e256-e258.
Copyright: © 2026 Polish Dermatological Association. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
